Levofloxacine Almus

Levofloxacin, the active ingredient in Levofloxacine Almus, is a fluoroquinolone presented as an oral tablet for systemic use. It treats a range of bacterial infections in adults, including respiratory, urinary and skin infections, and related bacterial DNA processes.

GNH USA supplies Levofloxacine Almus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable logistics for global distribution. Our network ensures timely delivery and support for healthcare providers across diverse markets.

Levofloxacin is indicated for several bacterial infections affecting the respiratory, urinary, and skin systems.

Community‑acquired respiratory tract infections: effective treatment of bacterial pneumonia and acute bronchitis. Urinary tract infections: eradicates common uropathogens causing cystitis and pyelonephritis. Skin and soft tissue infections: resolves cellulitis, abscesses, and wound infections caused by susceptible bacteria. Acute bacterial sinusitis: reduces sinus inflammation by eliminating causative organisms. Acute bacterial prostatitis: achieves bacterial clearance in prostate infections.

Levofloxacin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset often transient. - Diarrhea: loose stools that may be self‑limiting. - Headache: mild to moderate cranial discomfort. - Dizziness: transient vertigo or light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: risk of Achilles or other tendon tears, especially in older adults. - QT prolongation: potential cardiac arrhythmia requiring monitoring. - Severe allergic reactions: anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. - Central nervous system effects: seizures or psychosis in susceptible patients.

Before prescribing Levofloxacine Almus, clinicians should consider several safety considerations.

Renal impairment: dose adjustment may be required and renal function should be monitored. Hepatic disease: use with caution in patients with liver dysfunction. History of tendon disorders: avoid in individuals with prior tendon inflammation or rupture. Concomitant QT‑prolonging drugs: assess cardiac risk before co‑administration. Pregnancy and breastfeeding: safety not established; use only if benefits outweigh risks. Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and light.

Levofloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and risk of bleeding. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of central nervous system stimulation and seizures.

Moderate Interactions (Monitor Closely): - Theophylline: levofloxacin can raise plasma theophylline levels, requiring dose adjustment. - Corticosteroids: combined use may increase risk of tendon rupture. - Diabetic agents (e.g., insulin, sulfonylureas): may cause hypoglycemia; monitor blood glucose.